TransMedics Group, Inc.TMDXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank31
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P31
Within normal range
vs 2Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 2025-8.70%
Q3 2025-36.28%
Q2 202533.25%
Q1 2025217.48%
Q4 2024120.34%
Q3 2024-68.64%
Q2 20240.70%
Q1 2024377.18%
Q4 2023109.19%
Q3 2023-3027.48%
Q2 202356.63%
Q1 202369.18%
Q4 2022-22.28%
Q3 202243.11%
Q2 2022-4.01%
Q1 202217.29%
Q4 20213.39%
Q3 2021-18.82%
Q2 2021-51.65%
Q1 2021-10.36%
Q4 2020-27.90%
Q3 202041.36%
Q2 20201.95%
Q1 20207.79%
Q4 2019-20.05%
Q3 20196.01%
Q2 2019-29.24%
Q1 20196.27%
Q4 2018-61.49%
Q3 201823.60%
Q2 2018-7.84%
Q1 2018-6.10%
Q4 20174.72%
Q3 201717.21%
Q3 2017-2.08%
Q2 20170.00%